ℹ️
🇬🇧
Search
Search for people relevant for "Blood-brain barrier"
Blood-brain barrier
Person
Class
Person
Publication
Programmes
Export current view
RNDr. Ľubica Múčková Ph.D.
External academic staff at Faculty of Pharmacy in Hradec Králové
22 publications
Publications
publication
Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment
2021 |
First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
2021 |
Faculty of Pharmacy in Hradec Králové
publication
Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D-2 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole
2021 |
Publication without faculty affiliation
publication
Encapsulation of oxime K027 into cucurbit[7]uril: In vivo evaluation of safety, absorption, brain distribution and reactivation effectiveness
2020 |
Publication without faculty affiliation
publication
Exploring structure-activity relationship in tacrine-squaramide derivatives as potent Cholinesterase inhibitors
2019 |
Publication without faculty affiliation
publication
Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivators
2019 |
Publication without faculty affiliation
publication
Tacroximes: novel unique compounds for the recovery of organophosphorus-inhibited acetylcholinesterase
2019 |
Publication without faculty affiliation
publication
Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition
2024 |
First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
publication
Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity
2023 |
First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease
2023 |
Faculty of Pharmacy in Hradec Králové, Faculty of Science
Load more publications (12)
Loading network view...